Cite
HARVARD Citation
Lake, B. et al. (2018). 28. Local experience at DGH shows Combination Pertuzumab and Herceptin Nearly Doubles PCR Rate of Neo-adjuvant Chemotherapy (NAC) in HER2 Positive Breast Cancer. European journal of surgical oncology. 44 (11), pp. 1833-. [Online].